Frequency of late drug-eluting stent thrombosis with non-cardiac surgery.

Abstract

Drug-eluting stents (DES) are highly effective in reducing restenosis but have a small but significant risk for late stent thrombosis (LAST). Cessation of antiplatelet drugs for noncardiac surgery has been implicated in precipitating LAST, prompting surgery to be done on antiplatelet therapy, with all the attendant bleeding risks, or deferred until 12… (More)
DOI: 10.1016/j.amjcard.2010.02.006

Topics

  • Presentations referencing similar topics